newsfilter
← Latest News
Business Wire·

AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference

  • AN2 Therapeutics, Inc. (NASDAQ: ANTX) announced that Co-Founder, Chairman, President & CEO Eric Easom will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference.
  • The fireside chat is scheduled for Wednesday, December 3, 2025, at 10:50 AM ET.
  • Members of AN2 Therapeutics management will be available for one-on-one meetings during the event.
  • A webcast of the presentation will be accessible via the Investors section of the company's website at www.an2therapeutics.com.
  • An archived replay of the presentation will be available for at least 30 days following the event.
  • AN2 Therapeutics is a biopharmaceutical company developing novel small molecule therapeutics using its boron chemistry platform.
  • The company's pipeline includes boron-based compounds for Chagas disease, melioidosis, NTM lung disease caused by M. abscessus, oncology, & other infectious diseases.
  • Lucy O. Day serves as Chief Financial Officer, while Anne Bowdidge handles investor & media relations.